The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Open accessAbstract
The cannabinoid CB 2 receptor (CB 2 R) represents a promising therapeutic target for various forms of tissue injury and inflammatory diseases. Although numerous compounds have been developed and widely used to target CB 2 R, their selectivity, molecular mode of action and pharmacokinetic properties have been poorly characterized. Here we report the most extensive characterization of the molecular pharmacology of the most widely used CB 2 R ligands to date. In a collaborative effort between multiple academic and industry laboratories, we identify marked differences in the ability of certain agonists to activate distinct signalling pathways and to cause off-target effects. We reach a consensus that HU910, HU308 and JWH133 are the recommended selective CB 2 R agonists to study the role of CB 2 R in biological and disease processes. We believe that our unique approach would be highly suitable for the characterization of other therapeutic targets in drug discovery research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Self-citationAnimal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
Policy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Distribution of cannabinoid receptors in the central and peripheral nervous system
Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A., & Novick, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 484
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 414
Self-citationSelection criteria for drug‐like compounds
Muegge, I. (2003) · Medicinal Research Reviews · doi:10.1002/med.10041 · Cited by 412
Early phytocannabinoid chemistry to endocannabinoids and beyond
Mechoulam, R., Hanuš, L. O., Pertwee, R., & Howlett, A. C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3811 · Cited by 393
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Banker, M. J., Clark, T. H., & Williams, J. A. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10332 · Cited by 305
The [35S]GTPγS binding assay: approaches and applications in pharmacology
Harrison, C., & Traynor, J. R. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.07.005 · Cited by 302
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Maccarrone, M., Guzmán, M., Mackie, K., Doherty, P., & Harkany, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3846 · Cited by 298
Self-citationWhy do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290
Self-citationCB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Dhopeshwarkar, A., & Mackie, K. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094649 · Cited by 257
Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
Batkai, S., Osei‐Hyiaman, D., Pan, H., El‐Assal, O., Rajesh, M., Mukhopadhyay, P., Hong, F., Harvey‐White, J., Jafri, A., Haskó, G., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7451com · Cited by 246
Self-citationWhat makes a good drug target?
Gashaw, I., Ellinghaus, P., Sommer, A., & Asadullah, K. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.007 · Cited by 240
van der Westhuizen, E. T., Breton, B., Christopoulos, A., & Bouvier, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.088880 · Cited by 225
Mukhopadhyay, P., Rajesh, M., Pan, H., Patel, V., Mukhopadhyay, B., Bátkai, S., Gao, B., Haskó, G., & Pacher, P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.022 · Cited by 220
Self-citationCB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
Montecucco, F., Lenglet, S., Braunersreuther, V., Burger, F., Pelli, G., Bertolotto, M., Mach, F., & Steffens, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.014 · Cited by 182
The Endocannabinoid System in Human Keratinocytes
Maccarrone, M., Di Rienzo, M., Battista, N., Gasperi, V., Guerrieri, P., Rossi, A., & Finazzi-Agrò, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303994200 · Cited by 166
Self-citationRole of the endocannabinoid system in diabetes and diabetic complications
Gruden, G., Barutta, F., Kunos, G., & Pacher, P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13226 · Cited by 161
Self-citationDi, L., Keefer, C. E., Scott, D. O., Strelevitz, T. J., Chang, G., Bi, Y., Lai, Y., Duckworth, J., Fenner, K. S., Troutman, M. D., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.043 · Cited by 160
Rajesh, M., Pan, H., Mukhopadhyay, P., Bátkai, S., Osei‐Hyiaman, D., Haskó, G., Liaudet, L., Gao, B., & Pacher, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307180 · Cited by 155
Self-citationTherapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 138
Ostenfeld, T., Price, J. A., Albanese, M., Bullman, J., Guillard, F., Meyer, I., Leeson, R., Costantin, C., Ziviani, L., Nocini, P. F., et al. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318219799a · Cited by 126
Yao, B. B., Mukherjee, S., Fan, Y., Garrison, T. R., Daza, A. V., Grayson, G. K., Hooker, B. A., Dart, M. J., Sullivan, J. P., & Meyer, M. D. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706838 · Cited by 120
Horváth, B., Magid, L., Mukhopadhyay, P., Bátkai, S., Rajesh, M., Park, O., Tanchian, G., Gao, R. Y., Goodfellow, C. E., Glass, M., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01381.x · Cited by 115
Self-citationCawston, E. E., Redmond, W. J., Breen, C. M., Grimsey, N. L., Connor, M. A., & Glass, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12329 · Cited by 110
Self-citationLatest advances in cannabinoid receptor agonists
Thakur, G. A., Tichkule, R. B., Bajaj, S., & Makriyannis, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903436505 · Cited by 87
Falenski, K. W., Thorpe, A. J., Schlosburg, J. E., Cravatt, B. F., Abdullah, R. A., Smith, T. H., Selley, D. E., Lichtman, A. H., & Sim‐Selley, L. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.44 · Cited by 82
Self-citationBaggelaar, M. P., Janssen, F. J., van Esbroeck, A. C. M., den Dulk, H., Allarà, M., Hoogendoorn, S., McGuire, R., Florea, B. I., Meeuwenoord, N. J., van den Elst, H., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306295 · Cited by 79
Self-citationGrimsey, N. L., Graham, E. S., Dragunow, M., & Glass, M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.007 · Cited by 76
Self-citationMurineddu, G., Lazzari, P., Ruiu, S., Sanna, A., Loriga, G., Manca, I., Falzoi, M., Dessì, C., Curzu, M. M., Chelucci, G., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060920d · Cited by 74
Zamek‐Gliszczynski, M. J., Ruterbories, K. J., Ajamie, R. T., Wickremsinhe, E. R., Pothuri, L., Rao, M. V. S., Basavanakatti, V. N., Pinjari, J., Ramanathan, V. K., & Chaudhary, A. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22452 · Cited by 73
Nicolussi, S., Paredes, J. M. V., Gachet, M. S., Rau, M., Flores-Soto, M. E., Blunder, M., & Gertsch, J. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.12.010 · Cited by 70
Self-citationOddi, S., Dainese, E., Sandiford, S. L., Fezza, F., Lanuti, M., Chiurchiù, V., Totaro, A., Catanzaro, G., Barcaroli, D., Laurenzi, V. D., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01658.x · Cited by 67
Self-citationMussinu, J., Ruiu, S., Mulè, A. C., Pau, A., Carai, M. A. M., Loriga, G., Murineddu, G., & Pinna, G. A. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00319-x · Cited by 63
A Continuous, Fluorescence-based Assay of µ-Opioid Receptor Activation in AtT-20 Cells
Knapman, A., Santiago, M., Du, Y. P., Bennallack, P. R., Christie, M. J., & Connor, M. A. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112461376 · Cited by 63
Self-citationLane, J. R., Beukers, M. W., Mulder‐Krieger, T., & IJzerman, A. P. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.024 · Cited by 52
Poirier, A., Cascais, A., Bader, U., Portmann, R., Brun, M.-E., Walter, I., Hillebrecht, A., Ullah, M., & Funk, C. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057943 · Cited by 47
Gattinoni, S., Simone, C. D., Dallavalle, S., Fezza, F., Nannei, R., Amadio, D., Minetti, P., Quattrociocchi, G., Caprioli, A., Borsini, F., et al. (2010) · ChemMedChem · doi:10.1002/cmdc.200900472 · Cited by 44
Self-citationvan der Stelt, M., Cals, J., Broeders-Josten, S., Cottney, J. E., van der Doelen, A. A., Hermkens, M., de Kimpe, V., King, A. W. T., Klomp, J. P. G., Oosterom, J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200916p · Cited by 40
Ullmer, C., Zoffmann, S., Bohrmann, B., Matile, H., Lindemann, L., Flor, P., & Malherbe, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02090.x · Cited by 37
Self-citationNicolussi, S., Chicca, A., Rau, M., Rihs, S., Soeberdt, M., Abels, C., & Gertsch, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.09.020 · Cited by 32
Self-citationA natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α
van der Wel, T., Janssen, F. J., Baggelaar, M. P., Deng, H., den Dulk, H., Overkleeft, H. S., & van der Stelt, M. (2015) · Journal of Lipid Research · doi:10.1194/jlr.d056390 · Cited by 30
Self-citationImproved accessibility to the desoxy analogues of Δ9-tetrahydrocannabinol and cannabidiol
Wilkinson, S. M., Price, J. R., & Kassiou, M. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.10.080 · Cited by 29
Cannabinoid receptor with an 'identity crisis' gets a second look
Rogers, N. (2015) · Nature Medicine · doi:10.1038/nm0915-966 · Cited by 25
Manley, P. J., Zartman, A. E., Paone, D. V., Burgey, C. S., Henze, D. A., Penna, K. B. D., Desai, R. R., Leitl, M. D., Lemaire, W., White, R. B., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.078 · Cited by 20
Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands
Holt, C. J. (2009) · Nottingham ePrints (University of Nottingham) · Cited by 1
Cited by
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Cannabinoid Ligands Targeting TRP Channels
Muller, C., Morales, P., & Reggio, P. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00487 · Cited by 567
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Hillard, C. J. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.130 · Cited by 445
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 439
Self-citationMammalian Transient Receptor Potential TRPA1 Channels: From Structure to Disease
Talavera, K., Startek, J. B., Alvarez-Collazo, J., Boonen, B., Alpizar, Y. A., Sanchez, A., Naert, R., & Nilius, B. (2020) · Physiological Reviews · doi:10.1152/physrev.00005.2019 · Cited by 403
Metadata
- Authors
- Soethoudt, M., Grether, U., Fingerle, J., Grim, T. W., Fezza, F., de Petrocellis, L., Ullmer, C., Rothenhäusler, B., Perret, C., van Gils, N., Finlay, D., MacDonald, C., Chicca, A., Gens, M. D., Stuart, J., de Vries, H., Mastrangelo, N., Xia, L., Alachouzos, G., Baggelaar, M. P., Martella, A., Mock, E. D., Deng, H., Heitman, L. H., Connor, M., Di Marzo, V., Gertsch, J., Lichtman, A. H., Maccarrone, M., Pacher, P., Glass, M., & van der Stelt, M.
- Venue
- Nature Communications
- Published
- 2017-01-03
- Volume
- 8
- Issue
- 1
- Pages
- 13958-13958
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2566514911
- Cited by
- 349
- References
- 64
- FWCI
- 23.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.